New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
08:35 EDTKERXKeryx Zerenex phase 2 data presentation selected for Kidney Foundation meeting
Keryx Biopharmaceuticals announced that Phase 2 clinical results of Zerenex in non-dialysis dependent chronic kidney disease patients with elevated serum phosphorus and iron deficiency anemia has been selected as a Late Breaking oral presentation at the National Kidney Foundation 2014 Spring Clinical Meeting, taking place April 22-26. This presentation, entitled "Zerenex for the Treatment of Iron-Deficiency Anemia and Reduction of Serum Phosphate in Non-Dialysis Dependent CKD," will be made during the Late Breaking Session on Friday, April 25.
News For KERX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
07:48 EDTKERXKeryx announces publication of Auryxia analysis
Subscribe for More Information
March 2, 2015
09:16 EDTKERXKeryx Auryxia outlook still positive, says Roth Capital
Subscribe for More Information
February 27, 2015
09:24 EDTKERXOn The Fly: Pre-market Movers
Subscribe for More Information
08:52 EDTKERXKeryx CFO to leave company by October
Keryx Biopharmaceuticals disclosed in a regulatory filing a planned consolidation of its finance and accounting function into its Boston office and that its CFO, James Oliviero, will be leaving Keryx by October. In connection with this transition, the company entered into an employment agreement with Oliviero that became effective on February 26 and will terminate on October 1, but may be extended upon the mutual agreement of the parties. The company has commenced a search for a new CFO who will be based in its Boston office. Oliviero will continue to manage the company’s finance and accounting team during the remainder of his tenure and will assist in the transition of his duties to the new CFO, Keryx said.
07:14 EDTKERXKeryx reports Q4 EPS (44c), consensus (37c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use